Wakefield Asset Management’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-31,393
Closed -$2.54M 156
2023
Q2
$2.54M Sell
31,393
-360
-1% -$29.4K 1.01% 37
2023
Q1
$2.56M Buy
+31,753
New +$2.56M 1.06% 34
2022
Q3
Sell
-41,058
Closed -$2.85M 174
2022
Q2
$2.85M Buy
41,058
+15,911
+63% +$1.18M 1.22% 14
2022
Q1
$1.93M Buy
+25,147
New +$1.81M 0.69% 46
2021
Q2
Sell
-29,465
Closed -$2.19M 162
2021
Q1
$2.19M Buy
+29,465
New +$2.24M 0.88% 45

Other funds holding HOLX

Wakefield Asset Management's HOLX Position: Q3 2023 in Review

Wakefield Asset Management sold out of Hologic (HOLX) in Q3 2023, closing a stake of 31,393 shares — an estimated $2.54M sold.

Wakefield Asset Management first reported a position in HOLX in Q1 2021 and held it in 5 quarters. The position peaked at $2.85M in Q2 2022. 692 funds tracked by Wall St. Rank hold HOLX as of Q3 2023.

  • Wakefield Asset Management reported no remaining Hologic position as of Q3 2023 after selling out during the quarter.
  • Wakefield Asset Management sold 31,393 Hologic shares in Q3 2023, an estimated $2.54M.
  • Wakefield Asset Management first reported a position in Hologic in Q1 2021 and held it in 5 quarters.
  • Wakefield Asset Management's Hologic position peaked at $2.85M in Q2 2022.
  • 692 funds tracked by Wall St. Rank held Hologic as of Q3 2023.

Based on Wakefield Asset Management's 13F filing for Q3 2023, filed 1 Nov 2023.